It does not extend to outpatient procedures such as B12 injections unless you are hospitalized and the injection is part of your treatment plan during your stay
reconstitute immediately before use for optimal integrity Analytical Verification Each peptide undergoes full analytical characterization to confirm identity, purity, and structural fidelity: HPLC Chromatography Confirms purity and retention profiles Mass Spectrometry Verifies molecular mass and sequence identity Peptide Mapping Confirms correct sequence alignment for each component Amino Acid Analysis Validates expected residue composition Endotoxin Testing Ensures researchgrade specifications Analytical documentation is provided for every lot to support reproducibility and experimental reliability
The peptide is often sold through unregulated channels as a 'research chemical' or unauthorised medicine, raising significant concerns about purity, dosage accuracy, and contamination
Daily Protocol: 1 to 2 mg subcutaneous injection once daily Alternate Protocol: 2 to 3 mg subcutaneous injection three times weekly Cycle Length: 8 to 12 weeks on Rest Period: 4 to 6 weeks off between cycles Cycles Per Year: 2 to 3 cycles recommended Injection Sites: Abdomen, outer thigh, or upper arm with rotation Cycling Recommendations Research suggests running GHK-Cu in cycles of 8 to 12 weeks followed by rest periods of 4 to 6 weeks
10.1016/j.ijbiomac.2023.124243 65 SantiniA.RonchiD.GarbelliniM.PigaD.ProttiA